Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIGEST: Long-Term Safety of Liprotamase in Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
NCT00449904Phase 3Completed
- Sponsor
- Anthera Pharmaceuticals, Inc.
- Start
- Jun 2007
- Primary completion
- Apr 2009
- Countries
- 1
01
Overview
A Phase 3 trial of liprotamase in exocrine pancreatic insufficiency (EPI), sponsored by Anthera Pharmaceuticals, Inc.. Started Jun 2007; status: completed.
02
Drugs
liprotamase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT00449904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449904.